The US Department of Justice (DoJ) has hailed the progress made in the year since the formation of Operation Synthetic Opioid Surge (SOS).
This program was designed to reduce the supply of deadly synthetic opioids in high impact areas of the USA, as well as identifying wholesale distribution networks and international and domestic suppliers.
During the past year, 10 districts with some of the highest drug overdose death rates in the country each targeted a county where they focused on prosecuting every readily-available case involving fentanyl, fentanyl analogues, and other synthetic opioids, regardless of the drug quantity.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze